Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (FRA:GU5)

Market Cap	4.47B -17.5%
Revenue (ttm)	9.46B +3.6%
Net Income	363.25M +5.2%
EPS	0.22 +5.2%
Shares Out	n/a
PE Ratio	12.30
Forward PE	12.60
Dividend	0.10 (5.21%)
Ex-Dividend Date	Aug 29, 2025

Volume	n/a
Average Volume	n/a
Open	1.850
Previous Close	1.830
Day's Range	1.850 - 1.850
52-Week Range	1.830 - 2.300
Beta	n/a
RSI	28.75
Earnings Date	Mar 20, 2026

About FRA:GU5

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People’s Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments. It is involved in the research, development, manufacturing, and sale of chemical drugs, chemical raw materials, and chemical raw material intermediates; and research, development, productio...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1997
• Employees: 27,057
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GU5

Financial Performance

In 2025, FRA:GU5's revenue was 77.66 billion, an increase of 3.55% compared to the previous year's 74.99 billion. Earnings were 2.98 billion, an increase of 5.21%.

Financial numbers in CNY